SearcharxivSearch

arXiv subjects

Rajan

Publications and source records attributed to Rajan.

2 recordsLinked to original sources

MolGraphBench: A Benchmark of GNN Architectures for Molecular Regression Tasks

Molecules are often represented as SMILES strings, which can be readily converted to hand-crafted descriptors or fingerprints (FP) for molecular property prediction. Research has demonstrated that SMILES can be converted to molecular graphs $G = (V, E)$, with atoms as nodes $(V)$ and bonds as edges $(E)$. These molecular graphs can subsequently be used to train graph neural networks (GNN) models. Despite the recent surge in application of GNN (existing and novel architectures) for molecular property prediction, a rigorous benchmark is still lacking. We propose MolGraphBench, a comprehensive benchmark of four commonly used GNN models for molecular property prediction. Benchmarking results demonstrate graph convolutional network (GCN) and graph isomorphism networks (GIN) as the optimal GNN architectures for molecular graph regression tasks, based on absolute performance, training efficiency, transfer learning and prediction quality. The study also indicates the non-complementary nature of molecular fingerprints in the fusion (GNN-FP) framework. Furthermore, our GNN models achieved performance superior or comparable performance to current state-of-the-art GNN baselines across three datasets (GCN with RMSE of $0.518$ on B3DB, GIN-FP with RMSE of $1.022$ on FreeSolv and GIN with MAE of $63.783$ on RT datasets). Findings from this study indicate that type of GNN-layer, should be treated as a tunable hyperparameter rather than a fixed design choice to achieve superior performance.

cs.LG

Predicting EGFR Mutation in LUAD from Histopathological Whole-Slide Images Using Pretrained Foundation Model and Transfer Learning: An Indian Cohort Study

Lung adenocarcinoma (LUAD) is a subtype of non-small cell lung cancer (NSCLC). LUAD with mutation in the EGFR gene accounts for approximately 46% of LUAD cases. Patients carrying EGFR mutations can be treated with specific tyrosine kinase inhibitors (TKIs). Hence, predicting EGFR mutation status can help in clinical decision making. H&E-stained whole slide imaging (WSI) is a routinely performed screening procedure for cancer staging and subtyping, especially affecting the Southeast Asian populations with significantly higher incidence of the mutation when compared to Caucasians (39-64% vs 7-22%). Recent progress in AI models has shown promising results in cancer detection and classification. In this study, we propose a deep learning (DL) framework built on vision transformers (ViT) based pathology foundation model and attention-based multiple instance learning (ABMIL) architecture to predict EGFR mutation status from H&E WSI. The developed pipeline was trained using data from an Indian cohort (170 WSI) and evaluated across two independent datasets: Internal test (30 WSI from Indian cohort) set, and an external test set from TCGA (86 WSI). The model shows consistent performance across both datasets, with AUCs of 0.933 (+/-0.010), and 0.965 (+/-0.015) for the internal and external test sets respectively. This proposed framework can be efficiently trained on small datasets, achieving superior performance as compared to several prior studies irrespective of training domain. The current study demonstrates the feasibility of accurately predicting EGFR mutation status using routine pathology slides, particularly in resource-limited settings using foundation models and attention-based multiple instance learning.

eess.IV